Giant Insurer Hits Pfizer with Damage Claim For Marketing Practices

Blue Cross Blue Shield insurance plans in four states are suing Pfizer and its Pharmacia & Upjohn subsidiary for fraudulently promoting three drugs and paying health care professionals to prescribe them, Courthouse News Service reports.

The lawsuit filed in federal court in Texas, according to the complaint, charges that Pfizer and Pharmacia inflated demand through deceptive marketing and kickbacks to doctors, causing insurers to spend hundreds of million of dollars on Pfizer’s drugs when they could have used lower-priced, safer drugs. The three drugs at issue are Bextra, an anti-inflammatory, Geodon, an anti-psychotic, and Lyrica, an epilepsy drug.

Health Care Service Corp. is the lead plaintiff in the suit and is suing on behalf of the Blue Cross Blue Shield plans that it operates in New Mexico, Oklahoma, Texas and Illinois.

The lawsuit is an offshoot of criminal and civil cases brought against Pfizer and Pharmacia by federal authorities for illegally marketing their drugs for unapproved uses. Pharmacia paid $1.3 billion in fines; Pfizer agreed to pay an additional $1 billion in civil settlements.

“This is a case of an insurance company seeking its money back for medicines that physicians prescribed appropriately using their best medical judgments,” Pfizer said in a statement to the Austin Business Journal. ”Pfizer denies the allegations brought by the insurer in this case.”

Print Print  

Like what we're doing? We'd appreciate your support.

Leave a comment